Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Lai

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 7, 2012
Metabolic switching of BILR 355 in the presence of ritonavir. I. Identifying an unexpected disproportionate human metaboliteYongmei Li, W George Lai, Andrea Whitcher-Johnstone, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 7, 2020
Metabolic disposition of H3B-8800, an orally available small-molecule splicing modulator, in rats, monkeys, and humansNathalie Rioux, Sherri Smith, Federico Colombo, et al.
Epilepsy & Behavior : E&B|December 12, 2018
The refractory epilepsy screening tool for Lennox-Gastaut syndrome (REST-LGS)Jesus Eric Piña-Garza, Danielle Boyce, David M Tworek, et al.
Cancer Research|May 20, 2016
Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic SeverityKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
Lab on a Chip|January 15, 2020
Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterizationStephen Fowler, Wen Li Kelly Chen, David B Duignan, et al.
British Journal of Clinical Pharmacology|January 18, 2018
Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugsMaiko Nomoto, Cynthia A Zamora, Edgar Schuck, et al.
Cell Communication and Signaling : CCS|June 19, 2019
Neuropilin-1 drives tumor-specific uptake of chlorotoxinSharon McGonigle, Utpal Majumder, Donna Kolber-Simonds, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 7, 2015
Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite groupHongbin Yu, Suresh K Balani, Weichao Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions-an Industry PerspectiveTonika Bohnert, Aarti Patel, Ian Templeton, et al.
Journal of Medicinal Chemistry|October 13, 2025
Accelerated <i>In Silico</i> Discovery of <b>SGR-1505</b>: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell MalignanciesZhe Nie, Michael Trzoss, Andrew T Placzek, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 7, 2012
Metabolic switching of BILR 355 in the presence of ritonavir. I. Identifying an unexpected disproportionate human metaboliteYongmei Li, W George Lai, Andrea Whitcher-Johnstone, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 7, 2020
Metabolic disposition of H3B-8800, an orally available small-molecule splicing modulator, in rats, monkeys, and humansNathalie Rioux, Sherri Smith, Federico Colombo, et al.
Epilepsy & Behavior : E&B|December 12, 2018
The refractory epilepsy screening tool for Lennox-Gastaut syndrome (REST-LGS)Jesus Eric Piña-Garza, Danielle Boyce, David M Tworek, et al.
Cancer Research|May 20, 2016
Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic SeverityKrystyna M Wozniak, James J Vornov, Ying Wu, et al.
Lab on a Chip|January 15, 2020
Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterizationStephen Fowler, Wen Li Kelly Chen, David B Duignan, et al.
British Journal of Clinical Pharmacology|January 18, 2018
Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugsMaiko Nomoto, Cynthia A Zamora, Edgar Schuck, et al.
Cell Communication and Signaling : CCS|June 19, 2019
Neuropilin-1 drives tumor-specific uptake of chlorotoxinSharon McGonigle, Utpal Majumder, Donna Kolber-Simonds, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 7, 2015
Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite groupHongbin Yu, Suresh K Balani, Weichao Chen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 8, 2016
Evaluation of a New Molecular Entity as a Victim of Metabolic Drug-Drug Interactions-an Industry PerspectiveTonika Bohnert, Aarti Patel, Ian Templeton, et al.
Journal of Medicinal Chemistry|October 13, 2025
Accelerated <i>In Silico</i> Discovery of <b>SGR-1505</b>: A Potent MALT1 Allosteric Inhibitor for the Treatment of Mature B-Cell MalignanciesZhe Nie, Michael Trzoss, Andrew T Placzek, et al.
Pageof 4